Journal: EJHaem

Article Title: Overuse of corticosteroids in patients with immune thrombocytopenia (ITP) between 2011 and 2017 in the United States

doi: 10.1002/jha2.684

Figure Lengend Snippet: Patient selection.

Article Snippet: The records of 22,900 and 50,428 patients with ITP during the period January 1, 2011 to July 31, 2017, were identified from the Explorys and MarketScan databases, respectively.

Techniques: Selection, Biomarker Discovery, Diagnostic Assay, Virus

Journal: EJHaem

Article Title: Overuse of corticosteroids in patients with immune thrombocytopenia (ITP) between 2011 and 2017 in the United States

doi: 10.1002/jha2.684

Figure Lengend Snippet: Baseline demographics and clinical characteristics.

Article Snippet: The records of 22,900 and 50,428 patients with ITP during the period January 1, 2011 to July 31, 2017, were identified from the Explorys and MarketScan databases, respectively.

Techniques:

Journal: EJHaem

Article Title: Overuse of corticosteroids in patients with immune thrombocytopenia (ITP) between 2011 and 2017 in the United States

doi: 10.1002/jha2.684

Figure Lengend Snippet: Overall CS use and ITP treatments utilized per LoT in the Explorys and MarketScan databases. Overall CS use across all LoTs in (A) the Explorys database and (B) the MarketScan database. ITP treatments utilized per LoT in (C) the Explorys database and (D) the MarketScan database. a The percentages add to >100% because some patients received more than one treatment in a given LoT. b Treatments presented have been sorted from highest to lowest percentages as used in LoT1 of each database. CS, corticosteroid; ITP, immune thrombocytopenia; LoT, line of treatment.

Article Snippet: The records of 22,900 and 50,428 patients with ITP during the period January 1, 2011 to July 31, 2017, were identified from the Explorys and MarketScan databases, respectively.

Techniques:

Journal: EJHaem

Article Title: Overuse of corticosteroids in patients with immune thrombocytopenia (ITP) between 2011 and 2017 in the United States

doi: 10.1002/jha2.684

Figure Lengend Snippet: Platelet counts per therapy type and LoT (Explorys database) and treatment regimens per LoT (MarketScan database). The proportion of patients per therapy type and LoT reaching a platelet count of ≥50 ⨯ 10 9 /L in the Explorys database. Patients receiving more than one treatment in a given LoT may be included more than once. (A) Treatment regimens in the MarketScan database, including type of regimen by LoT (B) and prednisone regimen by LoT (C). Regimen type (monotherapy or combination therapy) data were not available for the “Any CS” group. CS, corticosteroid; LoT, line of treatment.

Article Snippet: The records of 22,900 and 50,428 patients with ITP during the period January 1, 2011 to July 31, 2017, were identified from the Explorys and MarketScan databases, respectively.

Techniques:

Journal: JAMIA Open

Article Title: Validity of social media for assessing treatment patterns in oncology patients: a case study in melanoma

doi: 10.1093/jamiaopen/ooz013

Figure Lengend Snippet: Year of first line treatment initiation in each database

Article Snippet: Ipilimumab is the most common treatment given at first line in all databases as well as in the social media data, however the frequency reported in the databases varies from 16.7% (MarketScan) to 45.2% (McKesson).

Techniques:

Journal: JAMIA Open

Article Title: Validity of social media for assessing treatment patterns in oncology patients: a case study in melanoma

doi: 10.1093/jamiaopen/ooz013

Figure Lengend Snippet: Number of patients with data on first, second, and third line treatment

Article Snippet: Ipilimumab is the most common treatment given at first line in all databases as well as in the social media data, however the frequency reported in the databases varies from 16.7% (MarketScan) to 45.2% (McKesson).

Techniques:

Journal: JAMIA Open

Article Title: Validity of social media for assessing treatment patterns in oncology patients: a case study in melanoma

doi: 10.1093/jamiaopen/ooz013

Figure Lengend Snippet: First line treatment proportions and associated confidence intervals

Article Snippet: Ipilimumab is the most common treatment given at first line in all databases as well as in the social media data, however the frequency reported in the databases varies from 16.7% (MarketScan) to 45.2% (McKesson).

Techniques:

Journal: JAMIA Open

Article Title: Validity of social media for assessing treatment patterns in oncology patients: a case study in melanoma

doi: 10.1093/jamiaopen/ooz013

Figure Lengend Snippet: Second line treatment proportions and associated confidence intervals

Article Snippet: Ipilimumab is the most common treatment given at first line in all databases as well as in the social media data, however the frequency reported in the databases varies from 16.7% (MarketScan) to 45.2% (McKesson).

Techniques:

Journal: JAMIA Open

Article Title: Validity of social media for assessing treatment patterns in oncology patients: a case study in melanoma

doi: 10.1093/jamiaopen/ooz013

Figure Lengend Snippet: Third line treatment proportions and associated confidence intervals

Article Snippet: Ipilimumab is the most common treatment given at first line in all databases as well as in the social media data, however the frequency reported in the databases varies from 16.7% (MarketScan) to 45.2% (McKesson).

Techniques: